Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study

@inproceedings{Morelli2009ContinuousTV,
  title={Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study},
  author={Andrea Morelli and Christian Ertmer and Sebastian Rehberg and Matthias Lange and Alessandra Orecchioni and Valeria Cecchini and Alessandra Bachetoni and Mariadomenica D'Alessandro and Hugo Karel Van Aken and Paolo Pietropaoli and Martin Westphal},
  booktitle={Critical care},
  year={2009}
}
INTRODUCTION Recent clinical data suggest that early administration of vasopressin analogues may be advantageous compared to a last resort therapy. However, it is still unknown whether vasopressin and terlipressin are equally effective for hemodynamic support in septic shock. The aim of the present prospective, randomized, controlled pilot trial study was… CONTINUE READING